Notably, the soluble forms of some of these proteins, such as E-cadherin, junctional adhesion molecule A (JAM-A) and syndecan-1, have been shown to play a key role in tumor progression by modulating tumor microenvironments and high levels of these proteins in the serum are an indicator of poor prognosis [22–26]. This evidence concerns the gene CDH1 and neoplasm.